University of Crete (UOC)
Μελέτη της έκφρασης και των μηχανισμών ρύθμισης των γονιδίων p63 και p73 στον καρκίνο του ενδομητρίου
Abstract
dc:descriptionp63 plays an important role in several intracellular processes such as transcription activation and apoptosis. p63 has two N-terminal isoforms, TAp63 and DNp63. TAp63 isoform has p53-like functions, while DNp63 acts as a dominant negative inhibitor of the p53 family and is considered oncogenic. Although p63 and its isoforms are overexpressed in a wide variety of human malignancies such as cervical, head and neck, and lung cancer, their role in endometrial carcinoma has not been investigated. We measured by quantitative real-time polymerase chain reaction the mRNA expression of TAp63 and DNp63 in a series of 20 endometrioid adenocarcinomas paired with adjacent normal tissue. TAp63 isoform exhibited 1.8-fold overexpression in malignant samples, while DNp63 was 4.3-fold overexpressed in cancer specimens. Further analysis revealed that the DN/TA isoform ratio shifted from 0.5 in normal samples to 1.2 in tumor specimens. Statistical analysis also revealed an association of TAp63 expression with high body mass index (p = 0.034), late menopause (p = 0.020), and lower tumor grade (p = 0.034). DNp63 was also correlated with grade I/II tumors (p = 0.044). These results indicate that both p63 isoforms and especially DNp63 play an important role in the development and progression of grade I/II endoπmetrial adenocarcinoma, especially in obese and late-menopause women. p73 plays an important role in several intracellular processes such as transcription activation and apoptosis. Its promoters, P1 and P2, produce two different classes of proteins: those containing the transactivation domain (TAp73) and those lacking it (ΔNp73). TA-isoforms exhibit p53-like functions, while ΔΝ- isoforms act as dominant negative inhibitors of both wild-type p53 and TAp73. p73 is overexpressed in a wide variety of human tumors such as breast, lung, colon, bladder and ovarian cancer. We investigated the role of p73 isoforms in endometrial adenocarcinoma in a series of 20 tumor and adjacent normal tissue samples. Mrna expression of TAp73 and ΔNp73 was measured by real- time PCR, while the methylation profile of promoters P1 and P2 was examined by methylation-specific PCR (MSP). Methylation analysis showed that P1 promoter was unmethylated in all normal and malignant samples, while TAp73 expression levels were higher in 7/20 (35%), lower in 3/20 (15%) and normal in 10/20 (50%) tumor specimens. On the contrary, P2 promoter was methylated in 10/20 (50%), unmethylated in 2/20 (10%) and unmethylated only in the tumor specimen in 6/20 (30%) samples, respectively. This finding was in accordance with ΔNp73 mRNA expression, since ΔNp73 was not expressed in 10/20 (50%) samples, while in 7/20 (35%) samples it was only expressed in the tumor specimen. From the above results we deduce that the demethylation of P2 promoter and the subsequent expression of ΔΝp73 in tumor specimens is a key event in the development and progression of endometrial cancer.
Degree
thesis:*- Grantor dc:publisher
- University of Crete (UOC)
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Βακωνάκη, Ελένη
- Vakonaki, Eleni
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/27723